|
1
|
Go AS, Mozaffarian D, Roger VL, Benjamin
EJ, Berry JD, Blaha MJ, Dai S, Ford ES, Fox CS, Franco S, et al:
Executive summary: Heart disease and stroke statistics-2014 update:
A report from the American Heart Association. Circulation.
129:399–410. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Rajendran P, Rengarajan T, Thangavel J,
Nishigaki Y, Sakthisekaran D, Sethi G and Nishigaki I: The vascular
endothelium and human diseases. Int J Biol Sci. 9:1057–1069. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Griendling KK and FitzGerald GA: Oxidative
stress and cardiovascular injury: Part I: Basic mechanisms and in
vivo monitoring of ROS. Circulation. 108:1912–1916. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Park YS, Kim J, Misonou Y, Takamiya R,
Takahashi M, Freeman MR and Taniguchi N: Acrolein induces
cyclooxygenase-2 and prostaglandin production in human umbilical
vein endothelial cells: Roles of p38 MAP kinase. Arterioscler
Thromb Vasc Biol. 27:1319–1325. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Schiro A, Wilkinson FL, Weston R, Smyth
JV, Serracino-Inglott F and Alexander MY: Endothelial
microparticles as conveyors of information in atherosclerotic
disease. Atherosclerosis. 234:295–302. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Fiers W, Beyaert R, Declercq W and
Vandenabeele P: More than one way to die: Apoptosis, necrosis and
reactive oxygen damage. Oncogene. 18:7719–7730. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Li H, Horke S and Förstermann U: Vascular
oxidative stress, nitric oxide and atherosclerosis.
Atherosclerosis. 237:208–219. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mitra S, Deshmukh A, Sachdeva R, Lu J and
Mehta JL: Oxidized low-density lipoprotein and atherosclerosis
implications in antioxidant therapy. Am J Med Sci. 342:135–142.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tricot O, Mallat Z, Heymes C, Belmin J,
Leseche G and Tedgui A: Relation between endothelial cell apoptosis
and blood flow direction in human atherosclerotic plaques.
Circulation. 101:2450–2453. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lu J, Mitra S, Wang X, Khaidakov M and
Mehta JL: Oxidative stress and lectin-like ox-LDL-receptor LOX-1 in
atherogenesis and tumorigenesis. Antioxid Redox Signal.
15:2301–2333. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chen TG, Chen TL, Chang HC, Tai YT, Cherng
YG, Chang YT and Chen RM: Oxidized low-density lipoprotein induces
apoptotic insults to mouse cerebral endothelial cells via a
Bax-mitochondria-caspase protease pathway. Toxicol Appl Pharmacol.
219:42–53. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li D and Mehta JL: Intracellular signaling
of LOX-1 in endothelial cell apoptosis. Circ Res. 104:566–568.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Aluyen JK, Ton QN, Tran T, Yang AE,
Gottlieb HB and Bellanger RA: Resveratrol: Potential as anticancer
agent. J Diet Suppl. 9:45–56. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Cavallaro A, Ainis T, Bottari C and
Fimiani V: Effect of resveratrol on some activities of isolated and
in whole blood human neutrophils. Physiol Res. 52:555–562.
2003.PubMed/NCBI
|
|
15
|
Wang H, Yang YJ, Qian HY, Zhang Q, Xu H
and Li JJ: Resveratrol in cardiovascular disease: What is known
from current research? Heart Fail Rev. 17:437–448. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Nakata R, Takahashi S and Inoue H: Recent
advances in the study on resveratrol. Biol Pharm Bull. 35:273–279.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li H and Förstermann U: Resveratrol: A
multifunctional compound improving endothelial function. Editorial
to: ‘Resveratrol supplementation gender independently improves
endothelial reactivity and suppresses superoxide production in
healthy rats’ by S. Soylemez et al. Cardiovasc Drugs Ther.
23:425–429. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Schmitt CA, Heiss EH and Dirsch VM: Effect
of resveratrol on endothelial cell function: Molecular mechanisms.
Biofactors. 36:342–349. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lin YL, Chang HC, Chen TL, Chang JH, Chiu
WT, Lin JW and Chen RM: Resveratrol protects against oxidized
LDL-induced breakage of the blood-brain barrier by lessening
disruption of tight junctions and apoptotic insults to mouse
cerebrovascular endothelial cells. J Nutr. 140:2187–2192. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Huang EW, Xue SJ, Li XY, Xu SW, Cheng JD,
Zheng JX, Shi H, Lv GL, Li ZG, Li Y, et al: EEN regulates the
proliferation and survival of multiple myeloma cells by
potentiating IGF-1 secretion. Biochem Biophys Res Commun.
447:271–277. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Peng H, Zhong W, Zhao H, Chen L, Zhou X,
Li F, Zhu W and Li G: Lack of PGC-1α exacerbates high
glucose-induced apoptosis in human umbilical vein endothelial cells
through activation of VADC1. Int J Clin Exp Pathol. 8:4639–4650.
2015.PubMed/NCBI
|
|
22
|
Green DR and Reed JC: Mitochondria and
apoptosis. Science. 281:1309–1312. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Tait SW and Green DR: Mitochondria and
cell death: Outer membrane permeabilization and beyond. Nat Rev Mol
Cell Biol. 11:621–632. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
24
|
Deshmukh M and Johnson EM Jr: Evidence of
a novel event during neuronal death: Development of
competence-to-die in response to cytoplasmic cytochrome c. Neuron.
21:695–705. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Renaud SC, Gueguen R, Schenker J and
d'Houtaud A: Alcohol and mortality in middle-aged men from eastern
France. Epidemiology. 9:184–188. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Fukao H, Ijiri Y, Miura M, Hashimoto M,
Yamashita T, Fukunaga C, Oiwa K, Kawai Y, Suwa M and Yamamoto J:
Effect of trans-resveratrol on the thrombogenicity and
atherogenicity in apolipoprotein E-deficient and low-density
lipoprotein receptor-deficient mice. Blood Coagul Fibrinolysis.
15:441–446. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yang X, Li X and Ren J: From French
Paradox to cancer treatment: Anti-cancer activities and mechanisms
of resveratrol. Anticancer Agents Med Chem. 14:806–825. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Perez-Vizcaino F, Duarte J and
Andriantsitohaina R: Endothelial function and cardiovascular
disease: Effects of quercetin and wine polyphenols. Free Radic Res.
40:1054–1065. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Rossi L, Mazzitelli S, Arciello M, Capo CR
and Rotilio G: Benefits from dietary polyphenols for brain aging
and Alzheimer's disease. Neurochem Res. 33:2390–2400. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Besbes S, Mirshahi M, Pocard M and Billard
C: New dimension in therapeutic targeting of BCL-2 family proteins.
Oncotarget. 6:12862–12871. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Boatright KM and Salvesen GS: Mechanisms
of caspase activation. Curr Opin Cell Biol. 15:725–731. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Johnson TM, Yu ZX, Ferrans VJ, Lowenstein
RA and Finkel T: Reactive oxygen species are downstream mediators
of p53-dependent apoptosis. Proc Natl Acad Sci USA. 93:11848–11852.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ladurner A, Schachner D, Schueller K,
Pignitter M, Heiss EH, Somoza V and Dirsch VM: Impact of
trans-resveratrol-sulfates and -glucuronides on endothelial nitric
oxide synthase activity, nitric oxide release and intracellular
reactive oxygen species. Molecules. 19:16724–16736. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Li H, Xia N and Förstermann U:
Cardiovascular effects and molecular targets of resveratrol. Nitric
Oxide. 26:102–110. 2012. View Article : Google Scholar : PubMed/NCBI
|
